These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 12191692)
61. Formulation of a reservoir-type testosterone transdermal delivery system. Kim MK; Zhao H; Lee CH; Kim DD Int J Pharm; 2001 May; 219(1-2):51-9. PubMed ID: 11337165 [TBL] [Abstract][Full Text] [Related]
62. Potential mucoadhesive dosage form of lidocaine hydrochloride: II. In vitro and in vivo evaluation. Abu-Huwaij R; Assaf S; Salem M; Sallam A Drug Dev Ind Pharm; 2007 Apr; 33(4):437-48. PubMed ID: 17523008 [TBL] [Abstract][Full Text] [Related]
63. Simultaneously Improved Flame Retardance and Ceramifiable Properties of Polymer-Based Composites via the Formed Crystalline Phase at High Temperature. Li YM; Deng C; Shi XH; Xu BR; Chen H; Wang YZ ACS Appl Mater Interfaces; 2019 Feb; 11(7):7459-7471. PubMed ID: 30676017 [TBL] [Abstract][Full Text] [Related]
64. [Study on alpha-asarone reservoir-type patch]. Wu Z; Gao JQ; Chen HL; Hu Y; Liang WQ Zhongguo Zhong Yao Za Zhi; 2007 Mar; 32(6):484-7. PubMed ID: 17552150 [TBL] [Abstract][Full Text] [Related]
65. Ethylene-vinyl acetate copolymer microspheres for controlled release of macromolecules. Sefton MV; Brown LR; Langer RS J Pharm Sci; 1984 Dec; 73(12):1859-61. PubMed ID: 6527279 [TBL] [Abstract][Full Text] [Related]
66. Controlled delivery of taxol from microspheres composed of a blend of ethylene-vinyl acetate copolymer and poly (d,l-lactic acid). Burt HM; Jackson JK; Bains SK; Liggins RT; Oktaba AM; Arsenault AL; Hunter WL Cancer Lett; 1995 Jan; 88(1):73-9. PubMed ID: 7531612 [TBL] [Abstract][Full Text] [Related]
67. A polymeric device for delivery of anti-microbial and anti-fungal drugs in the oral environment: effect of temperature and medium on the rate of drug release. Lin DM; Kalachandra S; Valiyaparambil J; Offenbacher S Dent Mater; 2003 Nov; 19(7):589-96. PubMed ID: 12901982 [TBL] [Abstract][Full Text] [Related]
68. Modeling of drug release from biodegradable triple-layered microparticles. Lee WL; Shi WX; Low ZY; Li S; Loo SC J Biomed Mater Res A; 2012 Dec; 100(12):3353-62. PubMed ID: 22733705 [TBL] [Abstract][Full Text] [Related]
69. Exploiting hydrogen bonding to enhance lidocaine loading and stability in a poly ethylene-co-vinyl acetate carrier matrix. Agarwal P; Nieuwoudt MK; Li S; Procter G; Andrews GP; Jones DS; Svirskis D Int J Pharm; 2022 Jun; 621():121819. PubMed ID: 35569627 [TBL] [Abstract][Full Text] [Related]
70. Controlled-Release from High-Loaded Reservoir-Type Systems-A Case Study of Ethylene-Vinyl Acetate and Progesterone. Koutsamanis I; Paudel A; Nickisch K; Eggenreich K; Roblegg E; Eder S Pharmaceutics; 2020 Jan; 12(2):. PubMed ID: 32013050 [TBL] [Abstract][Full Text] [Related]
71. Effect of comonomer ratio on hydrocortisone diffusion from sustained-release composite capsules. Fu JC; Moyer DL; Hagemeier C J Biomed Mater Res; 1978 May; 12(3):249-54. PubMed ID: 670251 [TBL] [Abstract][Full Text] [Related]
72. The effect of the Nb2O5 dispersion on ethylene vinyl acetate to obtain ethylene vinyl acetate/Nb2O5 nanostructured materials. Valentim AC; Tavares MI; da Silva EO J Nanosci Nanotechnol; 2013 Jun; 13(6):4427-32. PubMed ID: 23862516 [TBL] [Abstract][Full Text] [Related]
73. Influence of menthol and pressure-sensitive adhesives on the in vivo performance of membrane-moderated transdermal therapeutic system of nicardipine hydrochloride in human volunteers. Krishnaiah YS; Satyanarayana V; Bhaskar P Eur J Pharm Biopharm; 2003 May; 55(3):329-37. PubMed ID: 12754008 [TBL] [Abstract][Full Text] [Related]
74. New insights on poly(vinyl acetate)-based coated floating tablets: characterisation of hydration and CO2 generation by benchtop MRI and its relation to drug release and floating strength. Strübing S; Abboud T; Contri RV; Metz H; Mäder K Eur J Pharm Biopharm; 2008 Jun; 69(2):708-17. PubMed ID: 18249530 [TBL] [Abstract][Full Text] [Related]
75. Towards Understanding the Chemical Structure Modification of EVA Copolymer upon MAPLE Processing of Thin Films. Niemczyk A; Brajnicov S; Satulu V; Baranowska J; Mitu B; Dinescu M Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769117 [TBL] [Abstract][Full Text] [Related]
76. Influences of modified bacterial cellulose nanofibers (BCNs) on structural, thermophysical, optical, and barrier properties of poly ethylene-co-vinyl acetate (EVA) nanocomposite. Ghadikolaei SS; Omrani A; Ehsani M Int J Biol Macromol; 2018 Aug; 115():266-272. PubMed ID: 29660460 [TBL] [Abstract][Full Text] [Related]
77. Enhanced bioavailability of atenolol by transdermal administration of the ethylene-vinyl acetate matrix in rabbits. Shin SC; Choi JS Eur J Pharm Biopharm; 2003 Nov; 56(3):439-43. PubMed ID: 14602188 [TBL] [Abstract][Full Text] [Related]
78. Can drug release rate from implants be tailored using poly(urethane) mixtures? Lowinger MB; Su Y; Lu X; Williams RO; Zhang F Int J Pharm; 2019 Feb; 557():390-401. PubMed ID: 30529658 [TBL] [Abstract][Full Text] [Related]
79. Assessment of hot-processability and performance of ethylcellulose-based materials for injection-molded prolonged-release systems: An investigational approach. Casati F; Briatico-Vangosa F; Baldi F; Melocchi A; Maroni A; Gazzaniga A; Zema L Int J Pharm; 2018 Sep; 548(1):400-407. PubMed ID: 29981413 [TBL] [Abstract][Full Text] [Related]
80. Influence of limonene on the bioavailability of nicardipine hydrochloride from membrane-moderated transdermal therapeutic systems in human volunteers. Krishnaiah YS; Satyanarayana V; Bhaskar P Int J Pharm; 2002 Oct; 247(1-2):91-102. PubMed ID: 12429488 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]